1-6 of 6
Nerea Castro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hip Replacement Surgery and Anticoagulation; A Mortality, Transfusion Need and Venous Thromboembolism Rate Analysis with Trinetx

Mario Rodríguez-Rodríguez, Nerea Castro-Quismondo, Denis Zafra-Torres, Alberto Blanco-Sánchez, Gema Hernandez-Ibarburu, Miguel Pedrera-Jimenez, Rosa Ayala, Joaquín Martínez-Lopez
Journal: Blood
Blood (2022) 140 (Supplement 1): 8540–8541.
https://doi.org/10.1182/blood-2022-160180
Published: 2022
Journal Articles

Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

Joaquín Martínez-López, MD PhD, María Linares, Maria Luz Morales, Alicia Arenas, Ivana Zagorac, Rosa M. Ayala, MD PhD, Nerea Castro, Inmaculada Rapado, PhD, Miguel Quintela-Fandino
Journal: Blood
Blood (2016) 128 (22): 1581.
https://doi.org/10.1182/blood.V128.22.1581.1581
Published: 2016
Journal Articles

Wilms’ Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

Carolina Martínez-Laperche, PhD, Mi Kwon, MD, Ana Carolina Franco, Carmen Chillon, Nerea Castro, Eduardo Anguita, MD PhD, Carlos Rodriguez, Sandra Dolz, Lourdes Hermosín, MD, Elena Buces, Miriam López-Parra, Maria Isabel Prieto, Fernando Ramos-Ortega, J Nicolás Rodriguez, Eva Barragan, PhD, Maite Gómez-Casares, Rosa M. Ayala, MD PhD, Joaquín Martínez, Marcos González, MD, José Luis Díez Martín, Ismael Buno, PhD
Journal: Blood
Blood (2014) 124 (21): 1036.
https://doi.org/10.1182/blood.V124.21.1036.1036
Published: 2014
Journal Articles

The Presence Of Residual Disease After Induction and/Or Consolidation Therapy Based On Wilms’ Tumor 1 (WT1) Expression Is a Strong Prognostic Factor For Relapse and Survival In AML

Carolina Martínez-Laperche, PhD, Mi Kwon, MD, Ana Carolina Franco-Villegas, Carmen Chillón, PhD, Nerea Castro, Sandra Dolz, Carlos Rodríguez-Medina, Eduardo Anguita, MD, PhD, Nuria Perez, Miriam López-Parra, MI Prieto Conde, F Rámos Ortega, J Nicolás Rodriguez, Lourdes Hermosín, MD, Jose Antonio García Marco, MD, Maite Gómez Casares, Eva Barragan, M. González, Joaquín Martínez López, Jóse Luis Díez Martín, Ismael Buno, PhD
Journal: Blood
Blood (2013) 122 (21): 1329.
https://doi.org/10.1182/blood.V122.21.1329.1329
Published: 2013
Journal Articles

Clinical and Biological Prognostic Factors Evaluation of Diffuse Large B-Cell Lymphoma Patients Relapsed or Refractory After Previous Line with Rituximab Plus Chemotherapy. Results of the Study PRO-R-IPI (NCT01369784),

Carlos Panizo, MD, Anny Jaramillo, MD, Gonzalo Gutierrez-Garcia, Francisco Javier Díaz, Eva González-Barca, MD, Raquel de Oña, Nerea Castro, Juan Manuel Sancho, María Flor García-Alvarez, Blanca Sanchez-Gonzalez, MD, PhD, Francisco Javier Peñalver, Jimena Cannata-Ortiz, Manuel Espeso, María José Requena, Santiago Gardella, Soledad Durán, Ana Pilar González-Rodríguez, Ricardo García-Muñoz, Maurizio Bendandi, MD, PhD, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 3654.
https://doi.org/10.1182/blood.V118.21.3654.3654
Published: 2011
Journal Articles

Impact of Rituximab-Based Therapy After Histological Transformation on High-Dose Therapy and Autologous Stem Cell Transplantation in Follicular Transformed Lymphomas

Jose Manuel Calvo-Villas, Alejandro Martín, Carlos Panizo, MD, Juan Manuel Sancho, Alba Redondo, José David González-Sanmiguel, Blanca Sanchez Gonzalez, MD, Maria José Requena, Eva González-Barca, MD, María José Rodríguez-Salazar, Nerea Castro, Viviana Paredes, Jorge Gayoso, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 4478.
https://doi.org/10.1182/blood.V118.21.4478.4478
Published: 2011